NOTUM from Apc-mutant cells biases clonal competition to initiate cancer.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
06 2021
Historique:
received: 05 03 2020
accepted: 07 04 2021
pubmed: 4 6 2021
medline: 6 10 2021
entrez: 3 6 2021
Statut: ppublish

Résumé

The tumour suppressor APC is the most commonly mutated gene in colorectal cancer. Loss of Apc in intestinal stem cells drives the formation of adenomas in mice via increased WNT signalling

Identifiants

pubmed: 34079124
doi: 10.1038/s41586-021-03525-z
pii: 10.1038/s41586-021-03525-z
pmc: PMC7615049
mid: EMS186856
doi:

Substances chimiques

Adenomatous Polyposis Coli Protein 0
Culture Media, Conditioned 0
Ligands 0
Wnt Proteins 0
adenomatous polyposis coli protein, mouse 0
Esterases EC 3.1.-
Notum protein, human EC 3.1.1.-
Notum protein, mouse EC 3.1.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

430-435

Subventions

Organisme : Wellcome Trust
ID : FC001204
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC001204
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001002
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206341/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206314/Z/17/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC001204
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R017247/1
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001002
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

Nature. 2012 Aug 30;488(7413):665-9
pubmed: 22895187
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11272-7
pubmed: 16055554
Nature. 2019 Oct;574(7779):532-537
pubmed: 31645730
Gastroenterology. 2009 Jun;136(7):2204-2213.e1-13
pubmed: 19248780
Nature. 2009 Jan 29;457(7229):608-11
pubmed: 19092804
Nat Cell Biol. 2019 Nov;21(11):1413-1424
pubmed: 31685988
Nature. 2019 Jul;571(7765):398-402
pubmed: 31292548
Science. 1997 Oct 3;278(5335):120-3
pubmed: 9311916
Nature. 2007 Oct 25;449(7165):1003-7
pubmed: 17934449
Gut. 2020 Jun;69(6):1092-1103
pubmed: 31563876
Science. 2013 Nov 22;342(6161):995-8
pubmed: 24264992
Cell. 2004 Apr 2;117(1):117-29
pubmed: 15066287
Nature. 2016 Oct 13;538(7624):260-264
pubmed: 27698416
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Nat Neurosci. 2010 Jan;13(1):133-40
pubmed: 20023653
Bioorg Med Chem Lett. 2016 Mar 15;26(6):1525-1528
pubmed: 26897593
Bone Res. 2019 Jan 8;7:2
pubmed: 30622831
Cell. 2010 Oct 1;143(1):134-44
pubmed: 20887898
Nature. 2012 Apr 29;485(7397):195-200
pubmed: 22575959
Dev Cell. 2011 Aug 16;21(2):366-74
pubmed: 21839923
J Cell Biol. 2004 Jul 5;166(1):37-47
pubmed: 15240568
Science. 1997 Mar 21;275(5307):1787-90
pubmed: 9065402
Nat Commun. 2019 Feb 13;10(1):723
pubmed: 30760720
Genesis. 2004 Jul;39(3):186-93
pubmed: 15282745
EMBO Rep. 2014 Jan;15(1):62-9
pubmed: 24355609
Cell Death Differ. 2017 Oct;24(10):1681-1693
pubmed: 28622298
Science. 1990 Jan 19;247(4940):322-4
pubmed: 2296722
Nat Commun. 2018 Mar 19;9(1):1132
pubmed: 29556067
Nature. 2015 Mar 12;519(7542):187-192
pubmed: 25731175
Nature. 1992 Sep 17;359(6392):235-7
pubmed: 1528264
Gastroenterology. 2015 Nov;149(6):1553-1563.e10
pubmed: 26170137
EMBO J. 1999 Nov 1;18(21):5931-42
pubmed: 10545105
PLoS One. 2016 Mar 14;11(3):e0150997
pubmed: 26974334

Auteurs

Dustin J Flanagan (DJ)

Cancer Research UK Beatson Institute, Glasgow, UK.

Nalle Pentinmikko (N)

Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
Molecular and Integrative Bioscience Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.

Kalle Luopajärvi (K)

Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
Molecular and Integrative Bioscience Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.

Nicky J Willis (NJ)

Alzheimer's Research UK UCL Drug Discovery Institute, University College London, London, UK.

Kathryn Gilroy (K)

Cancer Research UK Beatson Institute, Glasgow, UK.
SpecifiCancer CRUK Grand Challenge Team (C7932/A29055), Department of Genetics, Harvard Medical School, Boston, MA, USA.

Alexander P Raven (AP)

Cancer Research UK Beatson Institute, Glasgow, UK.
SpecifiCancer CRUK Grand Challenge Team (C7932/A29055), Department of Genetics, Harvard Medical School, Boston, MA, USA.

Lynn Mcgarry (L)

Cancer Research UK Beatson Institute, Glasgow, UK.

Johanna I Englund (JI)

Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
Molecular and Integrative Bioscience Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.

Anna T Webb (AT)

Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.

Sandra Scharaw (S)

Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden.

Nadia Nasreddin (N)

Intestinal Stem Cell Biology Lab, Wellcome Trust Centre Human Genetics, University of Oxford, Oxford, UK.

Michael C Hodder (MC)

Cancer Research UK Beatson Institute, Glasgow, UK.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

Rachel A Ridgway (RA)

Cancer Research UK Beatson Institute, Glasgow, UK.

Emma Minnee (E)

Cancer Research UK Beatson Institute, Glasgow, UK.
Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Nathalie Sphyris (N)

Cancer Research UK Beatson Institute, Glasgow, UK.

Ella Gilchrist (E)

Cancer Research UK Beatson Institute, Glasgow, UK.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

Arafath K Najumudeen (AK)

Cancer Research UK Beatson Institute, Glasgow, UK.

Beatrice Romagnolo (B)

Université de Paris, Institut Cochin, INSERM, CNRS, Paris, France.

Christine Perret (C)

Université de Paris, Institut Cochin, INSERM, CNRS, Paris, France.

Ann C Williams (AC)

Colorectal Tumour Biology Group, School of Cellular and Molecular Medicine, Faculty of Life Sciences, University of Bristol, Bristol, UK.

Hans Clevers (H)

SpecifiCancer CRUK Grand Challenge Team (C7932/A29055), Department of Genetics, Harvard Medical School, Boston, MA, USA.
Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, The Netherlands.

Pirjo Nummela (P)

Department of Pathology, Applied Tumor Genomics, Research Programs Unit and HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Marianne Lähde (M)

Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Wihuri Research Institute, University of Helsinki, Helsinki, Finland.

Kari Alitalo (K)

Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Wihuri Research Institute, University of Helsinki, Helsinki, Finland.

Ville Hietakangas (V)

Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
Molecular and Integrative Bioscience Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.

Ann Hedley (A)

Cancer Research UK Beatson Institute, Glasgow, UK.

William Clark (W)

Cancer Research UK Beatson Institute, Glasgow, UK.

Colin Nixon (C)

Cancer Research UK Beatson Institute, Glasgow, UK.

Kristina Kirschner (K)

Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

E Yvonne Jones (EY)

Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Ari Ristimäki (A)

Department of Pathology, Applied Tumor Genomics, Research Programs Unit and HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Simon J Leedham (SJ)

Intestinal Stem Cell Biology Lab, Wellcome Trust Centre Human Genetics, University of Oxford, Oxford, UK.

Paul V Fish (PV)

Alzheimer's Research UK UCL Drug Discovery Institute, University College London, London, UK.
The Francis Crick Institute, London, UK.

Jean-Paul Vincent (JP)

The Francis Crick Institute, London, UK.

Pekka Katajisto (P)

Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland. pekka.katajisto@helsinki.fi.
Molecular and Integrative Bioscience Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland. pekka.katajisto@helsinki.fi.
Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden. pekka.katajisto@helsinki.fi.

Owen J Sansom (OJ)

Cancer Research UK Beatson Institute, Glasgow, UK. o.sansom@beatson.gla.ac.uk.
SpecifiCancer CRUK Grand Challenge Team (C7932/A29055), Department of Genetics, Harvard Medical School, Boston, MA, USA. o.sansom@beatson.gla.ac.uk.
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. o.sansom@beatson.gla.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH